sibutramine has been researched along with Apnea, Obstructive Sleep in 6 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "6-month open-label weight loss trial combining sibutramine (a serotonin and noradrenaline reuptake inhibitor) with a 600-kcal deficit diet and exercise." | 7.75 | Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. ( Banerjee, D; Berend, N; Grunstein, RR; Magnussen, JS; Phillips, CL; Trenell, MI; Wang, D; Yee, BJ, 2009) |
| "Sibutramine has been increasingly used in the management of obesity, but is relatively contraindicated in patients with hypertension." | 5.34 | The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. ( Banerjee, D; Caterson, I; Grunstein, RR; Hedner, JA; Phillips, CL; Yee, BJ, 2007) |
| "The aim of the present study was to compare the efficacy of 1 yr of sibutramine-induced weight loss versus continuous positive airway pressure (CPAP) treatment on sleep-disordered breathing, cardiac autonomic function and systemic blood pressure in obese patients with obstructive sleep apnoea." | 5.14 | Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. ( Ferland, A; Poirier, P; Sériès, F, 2009) |
| "6-month open-label weight loss trial combining sibutramine (a serotonin and noradrenaline reuptake inhibitor) with a 600-kcal deficit diet and exercise." | 3.75 | Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. ( Banerjee, D; Berend, N; Grunstein, RR; Magnussen, JS; Phillips, CL; Trenell, MI; Wang, D; Yee, BJ, 2009) |
| "We screened male, symptomatic OSAHS patients who presented consecutively at the sleep clinic." | 2.71 | Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study. ( Basile, BR; Martinez, D, 2005) |
| "Obesity is frequently associated with other pathologies: cardiovascular, oncologic, systemic (diabetes) or oral." | 1.35 | [Obesity and oral health: risk factors of obese patients in dental practice]. ( Godlewski, AE; Nicolas, E; Veyrune, JL, 2008) |
| "Sibutramine has been increasingly used in the management of obesity, but is relatively contraindicated in patients with hypertension." | 1.34 | The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. ( Banerjee, D; Caterson, I; Grunstein, RR; Hedner, JA; Phillips, CL; Yee, BJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godlewski, AE | 1 |
| Veyrune, JL | 1 |
| Nicolas, E | 1 |
| Ferland, A | 1 |
| Poirier, P | 1 |
| Sériès, F | 1 |
| Phillips, CL | 2 |
| Yee, BJ | 2 |
| Trenell, MI | 1 |
| Magnussen, JS | 1 |
| Wang, D | 1 |
| Banerjee, D | 2 |
| Berend, N | 1 |
| Grunstein, RR | 2 |
| Martinez, D | 1 |
| Basile, BR | 1 |
| Caterson, I | 1 |
| Hedner, JA | 1 |
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Sibutramine-induced Weight Loss vs. Continuous Positive Airway Pressure (CPAP) in the Treatment of Obese Patients With Obstructive Sleep Apnea[NCT00729963] | Phase 4 | 45 participants (Actual) | Interventional | 2004-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sibutramine and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |
2 trials available for sibutramine and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients.
Topics: Adult; Appetite Depressants; Blood Pressure; Body Mass Index; Continuous Positive Airway Pressure; C | 2009 |
Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study.
Topics: Adult; Appetite Depressants; Blood Pressure; Cyclobutanes; Double-Blind Method; Heart Rate; Humans; | 2005 |
3 other studies available for sibutramine and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
[Obesity and oral health: risk factors of obese patients in dental practice].
Topics: Adult; Appetite Depressants; Child; Child, Preschool; Cyclobutanes; Dental Caries; Diabetes Mellitus | 2008 |
Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.
Topics: Adipose Tissue; Adiposity; Adult; Aged; Appetite Depressants; Biomarkers; Cardiovascular Diseases; C | 2009 |
The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea.
Topics: Adult; Aged; Appetite Depressants; Blood Pressure; Cohort Studies; Cyclobutanes; Heart Rate; Humans; | 2007 |